A detailed history of Strategic Wealth Partners, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 7,702 shares of ABT stock, worth $865,704. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,702
Previous 6,557 17.46%
Holding current value
$865,704
Previous $721,000 21.36%
% of portfolio
0.1%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$109.52 - $120.96 $125,400 - $138,499
1,145 Added 17.46%
7,702 $875,000
Q4 2023

May 20, 2024

SELL
$90.19 - $110.4 $94,428 - $115,588
-1,047 Reduced 13.77%
6,557 $721,000
Q3 2023

May 20, 2024

SELL
$95.53 - $114.62 $93,905 - $112,671
-983 Reduced 11.45%
7,604 $736,000
Q2 2023

May 20, 2024

BUY
$100.78 - $112.29 $23,683 - $26,388
235 Added 2.81%
8,587 $936,000
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $25,183 - $29,642
-260 Reduced 3.02%
8,352 $845,000
Q4 2022

Apr 24, 2023

BUY
$95.06 - $111.52 $57,226 - $67,135
602 Added 7.52%
8,612 $945,000
Q3 2022

Apr 24, 2023

BUY
$96.76 - $112.03 $21,867 - $25,318
226 Added 2.9%
8,010 $775,000
Q2 2022

Aug 22, 2022

SELL
$102.07 - $123.37 $100,028 - $120,902
-980 Reduced 11.18%
7,784 $846,000
Q1 2022

May 19, 2022

SELL
$114.02 - $139.04 $157,803 - $192,431
-1,384 Reduced 13.64%
8,764 $1.04 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $5,892 - $7,214
-51 Reduced 0.5%
10,148 $1.43 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $46,664 - $51,624
400 Added 4.08%
10,199 $1.21 Million
Q2 2021

Aug 25, 2021

BUY
$105.79 - $124.53 $741,270 - $872,581
7,007 Added 250.97%
9,799 $1.14 Million
Q1 2021

May 24, 2021

SELL
$108.84 - $128.23 $861,250 - $1.01 Million
-7,913 Reduced 73.92%
2,792 $335,000
Q4 2020

Feb 18, 2021

SELL
$105.0 - $114.42 $43,050 - $46,912
-410 Reduced 3.69%
10,705 $1.17 Million
Q3 2020

Nov 10, 2020

SELL
$91.64 - $111.29 $321,564 - $390,516
-3,509 Reduced 23.99%
11,115 $1.21 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $306,509 - $392,294
-4,003 Reduced 21.49%
14,624 $1.34 Million
Q1 2020

May 07, 2020

BUY
$62.82 - $91.86 $1.17 Million - $1.71 Million
18,627 New
18,627 $1.62 Million
Q4 2019

Jan 30, 2020

SELL
$78.51 - $87.4 $1.37 Million - $1.53 Million
-17,466 Closed
0 $0
Q3 2019

Oct 28, 2019

BUY
$81.84 - $88.74 $1.4 Million - $1.52 Million
17,075 Added 4367.01%
17,466 $20.4 Million
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $16,033 - $18,700
220 Added 128.65%
391 $32,000
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $4,701 - $5,684
71 Added 71.0%
171 $14,000
Q4 2018

Jan 24, 2019

SELL
$65.56 - $74.27 $26,224 - $29,708
-400 Reduced 80.0%
100 $7,000
Q3 2018

Dec 06, 2018

SELL
$60.81 - $73.36 $2,189 - $2,640
-36 Reduced 6.72%
500 $37,000
Q1 2018

Jul 13, 2018

BUY
$56.27 - $63.62 $30,160 - $34,100
536 New
536 $32,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Strategic Wealth Partners, Ltd. Portfolio

Follow Strategic Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.